This inventor holds 2 USPTO granted patents. Top assignee: Takeda Pharmaceutical Company Limited. Active years: 2022-2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022-2024
Title: Innovations of Philipp M Bärnthaler
Introduction
Philipp M Bärnthaler is a notable inventor based in Vienna, Austria. He has made significant contributions to the field of biotechnology, particularly in the purification of Factor VIII subspecies. His work has led to advancements that are crucial for medical applications.
Latest Patents
Philipp M Bärnthaler holds two patents related to the purification of Factor VIII subspecies. The first patent describes a method for purifying a Factor VIII (FVIII) subspecies from a composition comprising FVIII. This method includes an anion exchange chromatography step, a size exclusion chromatography step, and a concentration step. The invention also encompasses a composition comprising a purified FVIII subspecies. The second patent is similar in nature, focusing on the same purification method and composition.
Career Highlights
Philipp M Bärnthaler is associated with Takeda Pharmaceutical Company Limited, where he applies his expertise in biotechnology. His work at Takeda has allowed him to contribute to important research and development projects in the pharmaceutical industry.
Collaborations
Some of his notable coworkers include Meinhard Hasslacher and Martin Feichtinger. Their collaboration has likely enhanced the research and development efforts within their projects.
Conclusion
Philipp M Bärnthaler's innovations in the purification of Factor VIII subspecies demonstrate his commitment to advancing medical science. His contributions are vital for improving therapeutic options in healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile